ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

NCAB Says President’s Budget Would “Seriously Damage” Cancer Program

February 12, 1999

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001

AIDS Biological Specimens Available From NIH

November 22, 1985

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994